Atlas Trials

Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Clinical trial NCT06519526 · RECRUITING

Trial details

NCT number
NCT06519526
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed/Refractory Peripheral T Cell Lymphoma
Start date
2024-08-12
Primary completion
2027-02-28
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.